Total Payments
$12,243
2024 Payments
$1,109
Companies
31
Transactions
394
Medicare Patients
1,696
Medicare Billing
$281,127
Payment Breakdown by Category
Food & Beverage$10,436 (85.2%)
Travel$1,807 (14.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,436 | 391 | 85.2% |
| Travel and Lodging | $1,807 | 3 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2,500 | 77 | $0 (2024) |
| Nuvectra Corporation | $2,301 | 6 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,219 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $972.22 | 31 | $0 (2021) |
| Novo Nordisk Inc | $957.64 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $916.71 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $627.71 | 19 | $0 (2023) |
| Amgen Inc. | $444.23 | 22 | $0 (2021) |
| PFIZER INC. | $393.95 | 14 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $327.80 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,109 | 31 | E.R. Squibb & Sons, L.L.C. ($384.01) |
| 2023 | $1,094 | 27 | E.R. Squibb & Sons, L.L.C. ($401.31) |
| 2022 | $280.08 | 24 | Novo Nordisk Inc ($120.22) |
| 2021 | $1,658 | 73 | Boehringer Ingelheim Pharmaceuticals, Inc. ($299.76) |
| 2020 | $1,228 | 66 | AstraZeneca Pharmaceuticals LP ($274.09) |
| 2019 | $1,736 | 73 | Janssen Pharmaceuticals, Inc ($439.31) |
| 2018 | $3,128 | 55 | Nuvectra Corporation ($2,301) |
| 2017 | $2,009 | 45 | E.R. Squibb & Sons, L.L.C. ($560.21) |
All Payment Transactions
394 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $124.95 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.88 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $54.21 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $30.69 | General |
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.26 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $2.84 | General |
| Category: Cardiovascular | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.75 | General |
| Category: Cardiovascular | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.25 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $3.93 | General |
| Category: Cardiovascular | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $39.71 | General |
| Category: Cardiovascular | ||||||
| 05/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Cardiovascular | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $134.95 | General |
| Category: Cardiovascular | ||||||
| 04/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.40 | General |
| Category: Cardiovascular | ||||||
| 03/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.94 | General |
| Category: Cardiovascular | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 400 | 1,115 | $152,305 | $69,272 |
| 2022 | 9 | 434 | 1,445 | $187,570 | $86,200 |
| 2021 | 9 | 388 | 1,121 | $120,745 | $67,432 |
| 2020 | 9 | 474 | 1,044 | $119,995 | $58,222 |
Total Patients
1,696
Total Services
4,725
Medicare Billing
$281,127
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 75 | 419 | $52,375 | $26,494 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 183 | $40,260 | $18,232 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 134 | $26,800 | $8,502 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $12,900 | $6,115 | 47.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 14 | 92 | $8,280 | $3,835 | 46.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 32 | 33 | $6,600 | $3,782 | 57.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 182 | $3,640 | $1,529 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $700.00 | $475.58 | 67.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 15 | 15 | $750.00 | $306.90 | 40.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 71 | 456 | $57,000 | $27,257 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 198 | $43,470 | $20,393 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 184 | $33,270 | $13,536 | 40.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 22 | 175 | $15,750 | $7,693 | 48.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $11,500 | $5,689 | 49.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 20 | 110 | $12,100 | $5,610 | 46.4% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 32 | 36 | $7,200 | $4,005 | 55.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 14 | 39 | $3,120 | $1,401 | 44.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 90 | 208 | $4,160 | $616.65 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 155 | $27,125 | $16,644 | 61.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 205 | $24,600 | $15,097 | 61.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 37 | 178 | $22,250 | $10,822 | 48.6% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2021 | 20 | 189 | $17,010 | $8,408 | 49.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 19 | 127 | $13,970 | $7,685 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $8,200 | $6,113 | 74.6% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 11 | 11 | $2,200 | $1,247 | 56.7% |
About Dr. Manish Patel, MD
Dr. Manish Patel, MD is a Internal Medicine healthcare provider based in Elizabeth, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053418459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manish Patel, MD has received a total of $12,243 in payments from pharmaceutical and medical device companies, with $1,109 received in 2024. These payments were reported across 394 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,436).
As a Medicare-enrolled provider, Patel has provided services to 1,696 Medicare beneficiaries, totaling 4,725 services with total Medicare billing of $281,127. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elizabeth, NJ
- Active Since 09/20/2006
- Last Updated 04/19/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053418459
Products in Payments
- Algovita (Device) $2,301
- ELIQUIS (Drug) $1,942
- Ozempic (Drug) $570.06
- INVOKANA (Drug) $515.02
- CAMZYOS (Drug) $445.41
- XARELTO (Drug) $445.26
- FARXIGA (Drug) $428.85
- AREXVY (Drug) $374.95
- BREZTRI (Drug) $357.45
- JARDIANCE (Drug) $322.22
- Rybelsus (Drug) $247.76
- EUCRISA (Drug) $247.28
- SOLIQUA (Drug) $243.66
- Aimovig (Biological) $237.29
- TRELEGY ELLIPTA (Drug) $216.34
- ANORO ELLIPTA (Drug) $193.18
- ASCENDA (Device) $164.92
- Minimed 530G (Device) $146.23
- Otezla (Drug) $145.45
- AIRSUPRA (Drug) $137.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elizabeth
Sanjay Batta, M.d, M.D
Internal Medicine — Payments: $41,690
Internal Medicine $41,690
Dr. Francisco Munoz
Internal Medicine — Payments: $27,351
Internal Medicine $27,351
Ashraf Mansour, M.d, M.D
Internal Medicine — Payments: $22,769
Internal Medicine $22,769
Dr. James Perez
Internal Medicine — Payments: $18,977
Internal Medicine $18,977
Dr. Luis Benalcazar, M.d, M.D
Internal Medicine — Payments: $17,972
Internal Medicine $17,972
Mrs. Jean Pattathil, Md, MD
Internal Medicine — Payments: $14,602
Internal Medicine $14,602